Barrier or carrier? Pulmonary surfactant and drug delivery

A Hidalgo, A Cruz, J Pérez-Gil - European Journal of Pharmaceutics and …, 2015 - Elsevier
To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

[引用][C] Barrier or carrier? Pulmonary surfactant and drug delivery

A Hidalgo, A Cruz, J Pérez-Gil - European Journal of Pharmaceutics and …, 2015 - cir.nii.ac.jp
Barrier or carrier? Pulmonary surfactant and drug delivery | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Barrier or carrier? Pulmonary surfactant and drug delivery.

A Hidalgo, A Cruz, J Pérez-Gil - European Journal of Pharmaceutics …, 2015 - europepmc.org
To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

Barrier or carrier? Pulmonary surfactant and drug delivery

A Hidalgo, A Cruz, J Pérez-Gil - European Journal of Pharmaceutics …, 2015 - hero.epa.gov
To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

Barrier or carrier? Pulmonary surfactant and drug delivery

A Hidalgo, A Cruz, J Pérez-Gil - European journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

Barrier or carrier? Pulmonary surfactant and drug delivery

A Hidalgo, A Cruz, J Pérez-Gil - European Journal of Pharmaceutics and …, 2015 - infona.pl
To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …